» Articles » PMID: 36282028

Updated Estimates of Excess Total Mortality in Italy During the Circulation of the BA.2 and BA.4-5 Omicron Variants: April-July 2022

Overview
Journal Med Lav
Date 2022 Oct 25
PMID 36282028
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The impact of new lineages and sub-lineages of Omicron on total and excess mortality is largely unknown. This study aims to provide estimates of excess mortality during the circulation of the Omicron variant in Italy updated to July 2022.

Methods: Over-dispersed Poisson regression models, fitted separately for men and women, on 2011-2019 mortality data were used to estimate the expected number of deaths during the Covid-19 pandemic. The excess deaths were then obtained by the difference between observed and expected deaths and computed at all ages and at working ages (25-64 years).

Results: Between April and June 2022, we estimated 9,631 excess deaths (+6.3%) at all ages (4,400 in April, 3,369 in May, 1,862 in June) and 12,090 in July 2022 (+23.4%). At working ages, the excess was 763 (+4.9%) in April-June 2022 and 679 (+13.0%) in July 2022.

Conclusions: Excess total mortality persisted during the circulation of different lineages and sub-lineages of the Omicron variant in Italy. This excess was not limited to the elderly population but involved also working age individuals, though the absolute number of deaths was small. The substantial excess found in July 2022 is, however, largely attributable to high temperatures. At the end of the year, this may translate into 30 to 35,000 excess deaths, i.e. over 5% excess mortality. This reversed the long-term trend toward increasing life expectancy, with the relative implications in social security and retirement schemes.

Citing Articles

Neurofilament light chain and glial fibrillary acid protein levels are elevated in post-mild COVID-19 or asymptomatic SARS-CoV-2 cases.

Plantone D, Stufano A, Righi D, Locci S, Iavicoli I, Lovreglio P Sci Rep. 2024; 14(1):6429.

PMID: 38499607 PMC: 10948776. DOI: 10.1038/s41598-024-57093-z.


COVID-19 Marked a Change in the Scope of Occupational Medicine from Occupational to Work-Related Diseases and Total Worker Health®.

Corradi M, Ranzieri S Med Lav. 2023; 114(6):e2023053.

PMID: 38060207 PMC: 10731568. DOI: 10.23749/mdl.v114i6.15429.


No Excess Total Mortality in Italy in the First Semester of 2023 at All Ages and in the Working Age Population.

Alicandro G, Gerli A, Santucci C, Centanni S, Remuzzi G, La Vecchia C Med Lav. 2023; 114(5):e2023050.

PMID: 37878253 PMC: 10627104. DOI: 10.23749/mdl.v114i5.15275.


Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy, Italy.

Mannucci P, Antonella Galbussera A, DAvanzo B, Tettamanti M, Remuzzi G, Fortino I Intern Emerg Med. 2023; 18(5):1445-1451.

PMID: 37314640 DOI: 10.1007/s11739-023-03315-7.


Excess Total Mortality in Italy: An Update to February 2023 with Focus on Working Ages.

Alicandro G, Gerli A, Centanni S, Remuzzi G, La Vecchia C Med Lav. 2023; 114(3):e2023028.

PMID: 37309878 PMC: 10281071. DOI: 10.23749/mdl.v114i3.14740.


References
1.
Alicandro G, Remuzzi G, Centanni S, Gerli A, La Vecchia C . Excess total mortality during the Covid-19 pandemic in Italy: updated estimates indicate persistent excess in recent months. Med Lav. 2022; 113(2):e2022021. PMC: 9073760. DOI: 10.23749/mdl.v113i2.13108. View

2.
Woolf S, Chapman D, Sabo R, Zimmerman E . Excess Deaths From COVID-19 and Other Causes in the US, March 1, 2020, to January 2, 2021. JAMA. 2021; . PMC: 8019132. DOI: 10.1001/jama.2021.5199. View

3.
Alicandro G, Remuzzi G, La Vecchia C . COVID-19 pandemic and total mortality in the first six months of 2020 in Italy. Med Lav. 2020; 111(5):351-353. PMC: 7809978. DOI: 10.23749/mdl.v111i5.10786. View

4.
Aburto J, Scholey J, Kashnitsky I, Zhang L, Rahal C, Missov T . Quantifying impacts of the COVID-19 pandemic through life-expectancy losses: a population-level study of 29 countries. Int J Epidemiol. 2021; 51(1):63-74. PMC: 8500096. DOI: 10.1093/ije/dyab207. View

5.
Mehandru S, Merad M . Pathological sequelae of long-haul COVID. Nat Immunol. 2022; 23(2):194-202. PMC: 9127978. DOI: 10.1038/s41590-021-01104-y. View